Equity · Consumer defensive
e.l.f. Beauty, Inc. (ELF) perpetual futures
e.l.f. Beauty, Inc. is a beauty company that offers cosmetics and skin care products worldwide under brands including e.l.f. Cosmetics, e.l.f. Skin, Well People, Naturium and Keys Soulcare.
Price chart
Interactive TradingView chart
TradingView symbol NYSE:ELF
Loads TradingView's third-party widget (about 1 MB) on demand.
Trading data
Perpetual market activity
0/1 live markets
Trading data
Perpetual market activity
Spot performance
Venue matrix
1 markets
Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.
BingXTokenized wrappers of the real stock, tradable on-chain and on crypto exchanges around the clock. Premium/discount compares the token price to our stock reference price. Data: CoinMarketCap · Robinhood · DexScreener · GeckoTerminal.
| Product | Price | Premium vs stock | 24h Vol. | Market Cap | Chains |
|---|---|---|---|---|---|
| ELFRobinhood | $119.34 | – | $3 | $7k | Robinhood Chain |
| Exchange | Pair | Price | 24h Vol. | Liquidity |
|---|---|---|---|---|
 uniswapDEX · robinhood | ELF/USDG ↗ | $119.34 | $3 | $6k |
Best venues for this underlying
Best liquidity
-Tightest spread
-Highest volume
-Next catalyst
Catalysts
Next catalyst
Catalysts
No unusual perp activity right now.
Research data
Analysts, filings and peer context
Research data
Analysts, filings and peer context
Estimates
6Company events
6Peer comparison
Similar listed perpsRevenue mix
Latest annualAnalysts
Price targetsAnalyst rating history
RatingsOwnership
Institutional · 2026-Q3Reference market activity
ELF-PERPPrice performance
11Insider activity
FY2026 Q4Insider transactions
25e.l.f. Beauty officer Joshua Allen Franks sold 8,965 common shares in two open-market sales on 2026-11-05 at $120–$122.0032 per share, leaving 110,040 shares owned.
e.l.f. Beauty officer Joshua Allen Franks sold 7,926 common shares at $110.1529 in one open-market sale, leaving 119,005 shares owned.
e.l.f. Beauty officer Franks Joshua Allen sold 8,366 common shares in an open-market sale (code S) at $110.006 on Oct 12, 2026, leaving 126,931 shares owned.
CEO Tarang Amin exercised options on 71,000 shares at $26.84 and sold 47,000 shares in three open-market sales at $102.84-$105.01, leaving 134,496 shares owned.
Officer Mandy J. Fields sold 16,065 shares of e.l.f. Beauty common stock in 4 open-market sales on Sept 8, 2026 at prices from $103.83 to $106.61, leaving 90,896 shares owned.
e.l.f. Beauty officer Franks reported a gift of 3,300 common shares and an open-market sale of 200 shares at $110, leaving 135,297 shares held.
ELF CEO Tarang Amin reported Form 4 activity: 20,836 common shares gifted (G) and 20,326 shares in other (J) transactions on both acquired and disposed legs, plus 61,488 shares acquired via J-Other, all at $0.00.
CEO Tarang Amin exercised 71,000 options at $26.84, converting them into 71,000 common shares; 131,332 shares were held after.
e.l.f. Beauty officer Joshua Allen Franks sold 5,512 common shares at $110 in an open-market sale, leaving 138,797 shares owned.
Director Daniele Tiffany F. received a grant of 1,421 shares of e.l.f. Beauty common stock on 2026-08-20 at $0.00 per share, bringing her holdings to 8,258 shares.
Filings
31 · Latest SEC filingse.l.f. Beauty officer Joshua Allen Franks sold 8,965 common shares in two open-market sales on 2026-11-05 at $120–$122.0032 per share, leaving 110,040 shares owned.
e.l.f. Beauty officer Joshua Allen Franks sold 7,926 common shares at $110.1529 in one open-market sale, leaving 119,005 shares owned.
e.l.f. Beauty officer Franks Joshua Allen sold 8,366 common shares in an open-market sale (code S) at $110.006 on Oct 12, 2026, leaving 126,931 shares owned.
CEO Tarang Amin exercised options on 71,000 shares at $26.84 and sold 47,000 shares in three open-market sales at $102.84-$105.01, leaving 134,496 shares owned.
Officer Mandy J. Fields sold 16,065 shares of e.l.f. Beauty common stock in 4 open-market sales on Sept 8, 2026 at prices from $103.83 to $106.61, leaving 90,896 shares owned.
e.l.f. Beauty officer Franks reported a gift of 3,300 common shares and an open-market sale of 200 shares at $110, leaving 135,297 shares held.
ELF CEO Tarang Amin reported Form 4 activity: 20,836 common shares gifted (G) and 20,326 shares in other (J) transactions on both acquired and disposed legs, plus 61,488 shares acquired via J-Other, all at $0.00.
CEO Tarang Amin exercised 71,000 options at $26.84, converting them into 71,000 common shares; 131,332 shares were held after.
e.l.f. Beauty officer Joshua Allen Franks sold 5,512 common shares at $110 in an open-market sale, leaving 138,797 shares owned.
Director Matthew Farrell received 1,421 shares of e.l.f. Beauty common stock as a grant (A-Award) on Aug 20, 2026, at $0.00, leaving him with 12,241 shares.
Director Maria Ferreras received a grant (A-Award) of 1,909 shares of e.l.f. Beauty common stock on Aug 20, 2026 at $0.00, bringing her holdings to 3,933 shares.
Director Daniele Tiffany F. received a grant of 1,421 shares of e.l.f. Beauty common stock on 2026-08-20 at $0.00 per share, bringing her holdings to 8,258 shares.
Director Maureen C. Watson received a 1,939-share award of e.l.f. Beauty common stock on 2026-08-20, per Form 4 filed 2026-08-21. She held 4,684 shares afterward.
Director Keith Lori received a 1,985-share award of e.l.f. Beauty common stock under code A on 2026-08-20, leaving 24,683 shares owned.
Director Mitchell Kenneth Jr received a grant (A-Award) of 1,980 shares of e.l.f. Beauty common stock on 2026-08-20 at $0.00, bringing his holdings to 19,827 shares.
Director Gayle Tait received a grant of 1,421 shares of e.l.f. Beauty common stock on Aug 20, 2026, at $0.00 as compensation, not an open-market purchase. Tait held 6,623 shares afterward.
Director Charles V. Bergh received a grant of 1,878 shares of e.l.f. Beauty common stock at $0.00 on Aug 20, 2026, leaving him with 3,934 shares owned directly.
Transcripts
Earnings callsFY2027 Q22026-11-04
Earnings calls
AI summary
positivee.l.f. Beauty reported FY2027 Q2 net sales growth of 51% year over year, with Rhode contributing approximately 16 percentage points in the pre-annualization period and organic net sales up approximately 35%. Adjusted EBITDA rose 86% to $123 million. Gross margin was 71%, up about 160 basis points, including 30 basis points from tariff refunds flowing through COGS. Management raised its fiscal 27 outlook to 22-24% net sales growth from 18-20%, with organic growth of 9-11%, and raised adjusted EBITDA to $421-427 million. Tarang Amin highlighted a refreshed five-pillar strategy, the Rhode launch in Sephora Europe described as Sephora's largest launch ever, e.l.f. Cosmetics market share gains, and expansion into hair care and fragrance. Marketing spend shifted out of Q2 into the second half, and the company plans to reinvest $52 million of tariff refunds for a neutral full-year adjusted EBITDA impact.
Key takeaways
- Net sales grew 51% in Q2, the 31st consecutive quarter of net sales growth; organic net sales grew approximately 35%.
- Rhode contributed approximately 16 percentage points to net sales growth, and its Sephora Europe launch across 19 countries was described as Sephora's largest launch ever.
- e.l.f. Cosmetics gained 30 basis points of market share and reignited unit momentum; U.S. net sales grew 25% while international net sales grew 165%.
- e.l.f. Hair launched exclusively at Target in July with six products at $10 or less and entered Target's top 20 hair care brands and top 7 in styling within three months.
- Non-e.l.f. brand sales are now 30% of net sales, skincare is 23%, and manufacturing outside China has grown from 1% to nearly 70% over three years.
Financial highlights
- Q2 net sales grew 51% year over year, with pricing and product mix adding approximately 20 percentage points and unit volumes adding 31 percentage points.
- Q2 gross margin was 71%, up approximately 160 basis points, including 30 basis points from incremental refunds flowing through COGS.
- Q2 adjusted EBITDA was $123 million, up 86% from $66 million; adjusted net income was $73 million, or $1.21 per diluted share, versus $0.68 a year ago.
- Q2 adjusted SG&A was 53% of sales versus 56% last year; marketing and digital investment was 21% of net sales versus 23% last year. Cash on hand was $351 million with net leverage around 1x adjusted EBITDA.
Guidance
- FY27 net sales growth outlook raised to approximately 22-24% from 18-20%; organic net sales growth outlook raised to 9-11% from 6-7%.
- FY27 adjusted EBITDA outlook raised to $421-427 million from $401-407 million; adjusted net income $231-233 million and adjusted EPS $3.82-3.86 per diluted share.
- Second half net sales growth expected at approximately 7-10%, with Q3 above that range and Q4 below it due to prior-year launch timing.
- FY27 gross margin expected up approximately 250 basis points versus prior year, or approximately flat excluding tariff refunds; second half adjusted EBITDA margin expected in the low teens.
Q&A themes
- Rhode's Sephora Europe launch, retail versus DTC mix, and gross margin compression as retail distribution expands.
- e.l.f. brand market share gains, the pricing test on 10% of SKUs, and fall innovation performance.
- Expansion opportunities in hair care and fragrance, including e.l.f. Hair's early Target results and new consumers.
- International momentum in the UK, Germany, Canada, and Mexico/Brazil, plus connected commerce strength on Amazon and TikTok Shop.
Risks
- Second half gross margin is expected to be lower year over year as Rhode expands its retail presence.
- Q4 growth is guided below the second-half range due to difficult comparisons from prior-year launches, including Ulta space expansion, dm Germany, Rhode at Mecca, and Naturium at Walmart.
- The FY27 outlook assumes full reinvestment of $52 million in tariff refunds through lower prices and increased marketing, implying a neutral impact on full-year adjusted EBITDA.
FY2027 Q12026-08-05
Earnings calls
AI summary
positivee.l.f. Beauty reported Q1 fiscal 2027 net sales growth of 36%, marking its 30th consecutive quarter of net sales growth. Organic net sales excluding rhode were largely in line with the high single-digit decline previously outlooked. Rhode contributed approximately $160 million in net sales, ahead of expectations, driven by strong retail demand and a record-breaking DTC launch. U.S. net sales grew 29% and international grew 61%. Q1 gross margin was 83%, up approximately 1,400 basis points, including about 1,050 basis points from $50 million of IEEPA tariff refunds. Adjusted EBITDA was $168 million, up 93%. The company raised its fiscal 2027 outlook to 18%-20% net sales growth from 12%-14% and plans to fully reinvest the $50 million of tariff refunds, largely through price reductions on a subset of SKUs and increased marketing.
Key takeaways
- Net sales grew 36% in Q1, the 30th consecutive quarter of net sales growth.
- Rhode contributed approximately $160 million in net sales and outperformed expectations.
- The company raised its fiscal 2027 net sales growth outlook to 18%-20% from 12%-14%.
- Price discovery testing found about 90% of e.l.f. SKUs priced appropriately; about 10% will keep lower prices.
- The company plans to fully reinvest $50 million of IEEPA tariff refunds in fiscal 2027, largely through pricing actions and increased marketing.
Financial highlights
- Q1 net sales grew 36% year-over-year; U.S. net sales grew 29% and international net sales grew 61%.
- Q1 gross margin was 83%, up approximately 1,400 basis points; excluding tariff refunds it was up about 350 basis points.
- Q1 adjusted EBITDA was $168 million, up 93% from $87 million; excluding tariff refunds it was up 36%.
- Q1 adjusted net income was $105 million, or $1.75 per diluted share, versus $51 million, or $0.89 per diluted share, a year ago.
Guidance
- FY2027 net sales growth expected at approximately 18% to 20%, up from 12% to 14% previously.
- FY2027 adjusted EBITDA expected between $401 million and $407 million, up from $379 million to $385 million previously.
- FY2027 adjusted EPS expected at $3.50 to $3.55 per diluted share, up from $3.27 to $3.32 previously.
- FY2027 gross margin expected up approximately 200 basis points year-over-year; excluding tariff refunds, approximately flat.
Q&A themes
- Pricing actions and price discovery test: 90% of e.l.f. SKUs deemed appropriately priced, 10% to keep lower prices.
- Rhode's performance and planned September launch with Sephora in Europe across 19 countries.
- e.l.f. Hair launch, a Target exclusive for this fiscal year, in the approximately $17 billion U.S. haircare category.
- International expansion, including Boots in the U.K., Sephora in Brazil, and Naturium with Sephora in Canada and Mexico.
Risks
- Organic net sales excluding rhode were largely in line with the high single-digit decline outlooked for Q1.
- Unit volumes were down approximately 3 percentage points in Q1, while pricing and product mix added approximately 39 percentage points.
- Higher freight costs were cited, though management said they are already baked into the outlook.
Company news
Reuters, WSJ, Bloomberg and FT first, as far as our news provider delivers them; other publishers behind the second filter. Headlines link to the publisher.No articles from Reuters, WSJ, Bloomberg or FT for this company in our feed.
Company data
Company intelligence
Updated: Nov 9, 2026, 10:30 AM UTC
Company data
Company intelligence
Company profile
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Chief executive
- Tarang Amin
- Employees
- 849
- IPO date
- Sep 22, 2016
- Country
- US
- Exchange
- New York Stock Exchange
Rating factors
- Return on equityi
- 3
- Return on assetsi
- 3
- Debt to equityi
- 2
- Price to earningsi
- 1
- Price to booki
- 1
Company press releases
Congressional disclosures
Senate
House
Market cap history
Largest fund holders
| Fund | Weight | Shares held |
|---|---|---|
| IJH | 0.2% | 2.1M |
| XAW.TO | 0.01% | 2.1M |
| NJH | 0.09% | 2M |
| VTI | 0.01% | 1.8M |
| VB | 0.07% | 1.3M |
| VBK | 0.16% | 702.7K |
| VHCAX | 0.22% | 677.3K |
| VXF | 0.07% | 665.1K |
| MDY | 0.19% | 450.7K |
| DFAS | 0.12% | 362.5K |
| SPMD | 0.19% | 324K |
| SCHA | 0.17% | 314.6K |
Analyst track record
How the analysts covering ELF have done: ratings, price-target accuracy and the measured reaction after their calls.
| 12 months | 3 years | |
|---|---|---|
| Ratings | 136 | 429 |
| Analysts | 19 | 27 |
| Buy / hold / sell | 93 / 43 / 0 | 318 / 111 / 0 |
| Upgrades / downgrades / initiations | 0 / 0 / 3 | 5 / 8 / 8 |
| Price targets hit / missed | 89 / 37 (71%) | 153 / 233 (40%) |
| Avg. return after a rating (TipRanks) | +21.5% | -3.4% |
| Best / worst call | +132.3% / -17.0% | +132.3% / -55.3% |
After buy calls on this stock: median 21-day move +4.4% vs S&P 500 +4.0% (n = 320)
Most accurate on this stock
Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.
- Bill ChappellTruist Financial80% hit rate on this stock · 10 targets measuredHoldno targetJan 7, 2026
- Oliver ChenTD Cowen75% hit rate on this stock · 16 targets measuredBuytarget $110Aug 10, 2026
- Olivia TongRaymond James64% hit rate on this stock · 11 targets measuredBuytarget $117Sep 30, 2026
Latest ratings
| Date | Analyst | Call | Target | |
|---|---|---|---|---|
| Nov 10, 2026 | Dara MohsenianMorgan Stanley | HoldReiterated | $125 | article ↗ |
| Nov 5, 2026 | Unknown AnalystOppenheimer | HoldMaintained | – | article ↗ |
| Nov 5, 2026 | Anna LizzulBank of America Securities | BuyReiterated | $135 | article ↗ |
| Nov 5, 2026 | Andrea Faria TeixeiraJ.P. Morgan | BuyMaintained | $135 | article ↗ |
| Nov 5, 2026 | Anna GlaessgenB. Riley Securities | BuyMaintained | $140 | article ↗ |
TipRanks data · computed Nov 10, 2026 · 136 ratings
Embed this asset
<a href="https://perpequities.com/stocks/elf-perp"><img src="https://perpequities.com/badge/elf-perp.svg" width="240" height="64" alt="ELF perpetuals · perpequities.com" loading="lazy"></a>